Hunniwell Lake Ventures Launches Maiden Medical Device Fund

Hunniwell Lake Ventures

Palo Alto, CA-based Hunniwell Lake Ventures launched a new flagship fund focused on bringing intelligent technologies to surgical devices.

The Hunniwell Lake Healthcare Fund will focus on investing in emerging medical device companies with the potential to be billion-dollar international players, and in turn help raise the quality of healthcare and make surgical procedures more accessible worldwide.

These innovators should be challenging the status quo in surgical segments such as:

  • RF/ultrasonic surgical devices,
  • Advanced Laparoscopy/ Endoscopy,
  • Robotics and Visualization, and
  • Wound Care.

The firm is building a concentrated portfolio of 15 to 20 companies at the imminent or early revenue stages, with investments ranging up to $5M.

Richard Fang will be managing the fund alongside co-founder Daniel Teo.

Fang is the former CEO of Reach Surgical, a leading international brand of surgical instruments with presence in six continents around the world. Reach Surgical was recently sold to private equity. He is a Ph.D. in Physics from Purdue and formerly part of the R&D team at J&J. Fang brings 15 years of experience in the Chinese market for talent, distribution channels, supply chain, and strategic partnerships.

Daniel Teo was CFO of Reach Surgical, where he also had responsibilities for establishing and advancing all of its international businesses and joint ventures. He is a career CFO/COO who has orchestrated numerous fund-raising, acquisitions, and divestments for different companies. Teo is a graduate from Cambridge University majoring in (Medical) Physics, holds a Master’s degree from the Stanford Graduate School of Business as well as Accounting and Finance qualifications from the ACCA in London. FinSMEs 15/01/2020

Join the discussion